CRVL Corvel Corp.

CERIS Expands Services and Rebrands

CERIS Expands Services and Rebrands

Rapidly Growing Payment Integrity Firm Offers New Solutions in DRG Validation, Data Mining and More

FORT WORTH, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- CERIS, a CorVel company and a leader in both prepay and post-pay health care claims review, has expanded services and launched a top to bottom rebranding to communicate its enhanced value proposition.

CERIS has been a leader in prepay itemized bill review for three decades. It has expanded its service offerings to add innovative services such as full DRG validation review and a state-of-the-art methodology to perform fair and appropriate out-of-network repricing.

CERIS also performs post-payment itemized bill review, clinical coding reviews, implant reviews, chart to charge reviews and medical implant and transplant reviews. It brings to bear deep data mining and analytical capabilities that allow it to discover savings in 97% of all claims that it reviews. In implant claims alone, it obtains an average savings of 62% over original bills.

The rebranding includes the articulation of a specific purpose for CERIS: To help heal healthcare billing through transparency and integrity. The company’s overall vision is to become a beacon of integrity in the healthcare industry.

“As our company continues to grow, we revisit our mission and purpose so we remain aligned, relevant and authentic to who we are,” said company President, Greg Dorn. “Our commitment is to be proactive in meeting our clients’ emerging needs and steward our identity with integrity. Our goal is to remain a premier payment integrity partner.”

In addition to its rearticulated purpose and vision, CERIS will emphasize to its clients its dedication to accuracy and transparency in healthcare billing. Its client interactions are focused on integrity, reliability, dedication, professionalism and true partnership.

For more information visit , and follow us on .

About CERiS



, a leader in both prospective and retrospective claims review and repricing, combines clinical expertise and cost containment solutions to ensure the accuracy and transparency in healthcare payments. Accuracy and validation services include itemization review, DRG validation, facility repricing, contract and policy applications, review of implants and devices, and primary payer cost avoidance. Its proprietary universal chargemaster contains billions of charge items from more than 97% of the nation’s hospitals, helping to ensure the accuracy and objectivity of each claim review.

About CorVel



CorVel Corp. applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing worker’s compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

Contact: Melissa Storan
Phone: 949-851-1473


EN
29/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corvel Corp.

Corvel Corp: 3 directors

Three Directors at Corvel Corp sold/sold after exercising options 9,357 shares at between 108.090USD and 108.457USD. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the ...

 PRESS RELEASE

CorVel Announces Revenues and Earnings

CorVel Announces Revenues and Earnings FORT WORTH, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2025. Revenues for the quarter were $232 million, an increase from $207 million in the March quarter of 2024. Earnings per share for the quarter were $0.51, compared to $0.37 in the same quarter of the prior year.  Revenues for the fiscal year ended March 31, 2025 were $896 million, an increase from $795 million during the fiscal year ended March 31, 2024. Earnings per share for the fiscal year en...

 PRESS RELEASE

CorVel Earns 2025 Great Place To Work Certification™

CorVel Earns 2025 Great Place To Work Certification™ FORT WORTH, Texas, Feb. 25, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ:CRVL) is proud to be Certified™ by Great Place To Work® for the fifth year in a row. The prestigious award is based entirely on what current employees say about their experience working at CorVel. Great Place To Work® is the global authority on workplace culture, employee experience, and leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation. “We are very pleased to be recognized as a Great Place To Work f...

 PRESS RELEASE

CorVel Corporation Appoints Sarah Scott as Executive Vice President of...

CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah’s leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs...

 PRESS RELEASE

CorVel Announces Revenues and Earnings

CorVel Announces Revenues and Earnings FORT WORTH, Texas, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2024. Revenues for the quarter were $228 million, an increase from $202 million in the December quarter of 2023. Earnings per share for the quarter were $0.46, compared to $0.33 in the same quarter of the prior year. Revenues for the nine months ended December 31, 2024 were $664 million, an increase from $588 million during the nine months ended December 31, 2023. Earnings per share for the nine months ended...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch